Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunologic reconstitution following stem cell transplantation

T N Small1

  • 1Department of Pediatrics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA.

Current Opinion in Hematology
|November 1, 1996
PubMed
Summary

Bone marrow transplants require immune reconstitution for success. Opportunistic infections remain a major cause of mortality, especially after unrelated transplants, highlighting the need for improved immune recovery strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Graft-versus-host disease after double-unit cord blood transplantation has unique features and an association with engrafting unit-to-recipient HLA match.

Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation·2013
Same author

Alternative donor SCT for the treatment of MHC class II deficiency.

Bone marrow transplantation·2012
Same author

Live (vaccines) from New York.

Bone marrow transplantation·2012
Same author

T-cell-depleted hematopoietic SCT from unrelated donors for the treatment of congenital amegakaryocytic thrombocytopenia.

Bone marrow transplantation·2011
Same author

Legionella jordanis in hematopoietic SCT patients radiographically mimicking invasive mold infection.

Bone marrow transplantation·2011
Same author

Vaccination of SCT recipients.

Bone marrow transplantation·2010

Area of Science:

  • Immunology
  • Hematology
  • Transplantation Medicine

Background:

  • Bone marrow transplantation (BMT) success depends on immune system reconstitution.
  • Opportunistic infections are a leading cause of mortality post-BMT, particularly in unrelated transplants.
  • Despite advances, infection-related mortality has remained stagnant over the past five years.

Purpose of the Study:

  • To highlight the persistent challenge of opportunistic infections following BMT.
  • To underscore the significance of T- and B-cell deficits post-transplantation.
  • To introduce novel strategies for immune reconstitution.

Main Methods:

  • Review of recent unrelated bone marrow transplant series.
  • Analysis of mortality causes, focusing on infectious complications.

Related Experiment Videos

  • Evaluation of emerging immunotherapeutic approaches.

    • Main Results:

    • Fatal infections accounted for 16% (children) and 34% (adults) of mortality in recent unrelated BMT studies.
    • T- and B-cell deficiencies are recognized post-transplant defects.
    • Successful adoptive immunotherapy strategies have been reported to restore cellular immunity against cytomegalovirus and Epstein-Barr virus.

    Conclusions:

    • Immune reconstitution is critical for reducing nonrelapse mortality after BMT.
    • Adoptive immunotherapy shows promise in overcoming specific viral immune deficits.
    • Further research into immune recovery post-transplant is essential for improving patient outcomes.